Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Cellular Physiology|February 17, 2015
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regenerationSimona Pisanti, Paola Picardi, Valentina Pallottini, et al.
International Journal of Cancer|November 11, 2022
Advances in "adiponcosis": Insights in the inner mechanisms at the base of adipose and tumour tissues interplayCristina Pagano, Erika di Zazzo, Giorgio Avilia, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Towards an Improvement of Anticancer Activity of Benzyl Adenosine AnalogsVerdiana Covelli, Manuela Grimaldi, Rosario Randino, et al.
Pharmacology & Therapeutics|February 25, 2017
Cannabidiol: State of the art and new challenges for therapeutic applicationsSimona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Pharmacological Research|January 19, 2010
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depressionPalmiero Monteleone, Maurizio Bifulco, Giuseppe Maina, et al.
Scientific Reports|September 17, 2017
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancerMaria Chiara Proto, Donatella Fiore, Chiara Piscopo, et al.
Oncology Reports|December 4, 2009
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatinPatrizia Gazzerro, Anna M Malfitano, Maria Chiara Proto, et al.
Pharmaceutics|August 29, 2024
Inulin Amphiphilic Copolymer-Based Drug Delivery: Unraveling the Structural Features of Graft ConstructsCarla Sardo, Giulia Auriemma, Carmela Mazzacano, et al.
Journal of Translational Medicine|October 18, 2023
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancerMarzia Di Donato, Erika Di Zazzo, Annamaria Salvati, et al.
Pageof 4